OCGN
Price:
$1.14
Market Cap:
$328.16M
Ocugen, Inc., a clinical-stage biopharmaceutical company, focuses on the developing gene therapies to cure blindness diseases. The company's pipeline product includes OCU400, a novel gene therapy product candidate restoring retinal integrity and function across a range of genetically diverse inherited retinal diseases, such as retinitis pigmentosa and leber congenital amaurosis; OCU410, gene therapy candidate for the treatment of dry age-related macular degeneration (AMD); and OCU200, a novel fusion protein that is in preclinical development stage for the treatment of diabetic macular edema, diabetic retinopathy, and wet AMD. Ocugen, Inc. has a strategic partnership with CanSino Biologics In...[Read more]
Industry
Biotechnology
IPO Date
2014-12-03
Stock Exchange
NASDAQ
Ticker
OCGN
According to Ocugen, Inc.’s latest financial reports and current stock price. The company's current ROE is -139.20%. This represents a change of 213.99% compared to the average of -44.33% of the last 4 quarters.
The mean historical ROE of Ocugen, Inc. over the last ten years is 123.98%. The current -139.20% ROE has changed -212.27% with respect to the historical average. Over the past ten years (40 quarters), OCGN's ROE was at its highest in in the December 2018 quarter at 178.60%. The ROE was at its lowest in in the June 2017 quarter at -811.66%.
Average
123.98%
Median
-98.79%
Minimum
-192.64%
Maximum
1.89%
Discovering the peaks and valleys of Ocugen, Inc. ROE, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 705.03%
Maximum Annual ROE = 1.89%
Minimum Annual Increase = -296.22%
Minimum Annual ROE = -192.64%
Year | ROE | Change |
---|---|---|
2023 | -155.50% | 67.93% |
2022 | -92.60% | 52.03% |
2021 | -60.91% | -41.98% |
2020 | -104.98% | -45.50% |
2019 | -192.64% | -110.21% |
2018 | 1.89% | 705.03% |
2017 | 234.42% | -296.22% |
2016 | -119.47% | 5.19% |
2015 | -113.57% | 170.09% |
2014 | -42.05% | -223.56% |
The current ROE of Ocugen, Inc. (OCGN) is greater than its 3-year, greater than its 5-year, and less than than its 10-year historical averages
3-year avg
-103.01%
5-year avg
-121.33%
10-year avg
123.98%
Ocugen, Inc.’s ROE is less than Vaxart, Inc. (0%), greater than Novavax, Inc. (-114.19%), less than CohBar, Inc. (43.70%), greater than Rain Therapeutics Inc. (-55.32%), greater than Ocean Biomedical, Inc. (-81.52%), less than Elevation Oncology, Inc. (567.07%), greater than AVROBIO, Inc. (-57.97%), less than Zura Bio Limited (29.68%), greater than Enveric Biosciences, Inc. (-35.45%), greater than Hepion Pharmaceuticals, Inc. (-234.16%), greater than null (-328.66%),
Company | ROE | Market cap |
---|---|---|
0% | $201.33M | |
-114.19% | $1.86B | |
43.70% | $1.25M | |
-55.32% | $44.01M | |
-81.52% | $33.96M | |
567.07% | $36.94M | |
-57.97% | $5.24M | |
29.68% | $230.86M | |
-35.45% | $4.53M | |
-234.16% | $4.20M | |
-328.66% | $0 |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Ocugen, Inc. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Ocugen, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the ROE?
How can you use the ROE?
What is Ocugen, Inc.'s ROE?
How is the ROE calculated for Ocugen, Inc. (OCGN)?
What is the highest ROE for Ocugen, Inc. (OCGN)?
What is the 3-year average ROE for Ocugen, Inc. (OCGN)?
What is the 5-year average ROE for Ocugen, Inc. (OCGN)?
How does the current ROE for Ocugen, Inc. (OCGN) compare to its historical average?